| Bioactivity | HSD17B13-IN-103 (Compound 44) is a HSD17B13 inhibitor. HSD17B13-IN-103 can be used in the study of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)[1]. |
| CAS | 3035000-89-3 |
| Formula | C25H23F4N5O2 |
| Molar Mass | 501.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WO2024075051A1 |
HSD17B13-IN-103
CAS: 3035000-89-3 F: C25H23F4N5O2 W: 501.48
HSD17B13-IN-103 (Compound 44) is a HSD17B13 inhibitor. HSD17B13-IN-103 can be used in the study of non-alcoholic fatty l
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.